|Clinical and prognostic significance of coagulation assays in lung cancer|
F Tas, L Kilic, M Serilmez, S Keskin, F Sen, D Duranyildiz
Respiratory medicine 107 (3), 451-457, 2013
|Age is a prognostic factor affecting survival in lung cancer patients|
F Tas, R Ciftci, L Kilic, S Karabulut
Oncology letters 6 (5), 1507-1513, 2013
|Effect of carvedilol on silent anthracycline-induced cardiotoxicity assessed by strain imaging: a prospective randomized controlled study with six-month follow-up|
A Elitok, F Oz, AY Cizgici, L Kilic, R Ciftci, F Sen, Z Bugra, F Mercanoglu, ...
Cardiology journal 21 (5), 509-515, 2014
|Performance status of patients is the major prognostic factor at all stages of pancreatic cancer|
F Tas, F Sen, H Odabas, L Kılıc, S Keskın, I Yıldız
International journal of clinical oncology 18 (5), 839-846, 2013
|Noncutaneous melanoma have distinct features from each other and cutaneous melanoma|
F Tas, S Keskin, A Karadeniz, N Dağoğlu, F Sen, L Kilic, I Yildiz
Oncology 81 (5-6), 353-358, 2011
|The utility of FDG-PET/CT as an effective tool for detecting recurrent colorectal cancer regardless of serum CEA levels|
Y Sanli, S Kuyumcu, ZG Ozkan, L Kilic, E Balik, C Turkmen, D Has, G Isik, ...
Annals of nuclear medicine 26 (7), 551-558, 2012
|Prognostic factors in metastatic pancreatic cancer: Older patients are associated with reduced overall survival|
F Tas, F Sen, S Keskin, L Kilic, I Yildiz
Molecular and clinical oncology 1 (4), 788-792, 2013
|Clinical and prognostic significance of coagulation assays in advanced epithelial ovarian cancer|
F Tas, L Kilic, E Bilgin, S Keskin, F Sen, R Ciftci, I Yildiz, V Yasasever
International Journal of Gynecologic Cancer 23 (2), 2013
|Does beta-blocker therapy improve the survival of patients with metastatic non-small cell lung cancer?|
A Aydiner, R Ciftci, S Karabulut, L Kilic
Asian Pacific Journal of Cancer Prevention 14 (10), 6109-6114, 2013
|Clinical and prognostic significance of coagulation assays in gastric cancer|
F Tas, R Ciftci, L Kilic, M Serilmez, S Karabulut, D Duranyildiz
Journal of gastrointestinal cancer 44 (3), 285-292, 2013
|Coagulation tests show significant differences in patients with breast cancer|
F Tas, L Kilic, D Duranyildiz
Tumor Biology 35 (6), 5985-5992, 2014
|Current adjuvant treatment modalities for gastric cancer: from history to the future|
L Kilic, C Ordu, I Yildiz, F Sen, S Keskin, R Ciftci, KN Pilanci
World journal of gastrointestinal oncology 8 (5), 439, 2016
|D-dimer and international normalized ratio (INR) are correlated with tumor markers and disease stage in colorectal cancer patients|
L Kilic, I Yildiz, FK Sen, MG Erdem, M Serilmez, S Keskin, R Ciftci, ...
Cancer Biomarkers 15 (4), 405-411, 2015
|High serum transforming growth factor beta 1 (TGFB1) level predicts better survival in breast cancer|
R Ciftci, F Tas, CT Yasasever, E Aksit, S Karabulut, F Sen, S Keskin, ...
Tumor Biology 35 (7), 6941-6948, 2014
|Effect of increased body mass index (BMI) on time to tumour progression (TTP) in unresectable metastatic colorectal cancer (mCRC) patients treated with bevacizumab-based therapy|
NF Aykan, I Yildiz, F Sen, L Kilic, S Keskin, R Ciftci, S Karabulut, B Sakar, ...
Medical Oncology 30 (3), 679, 2013
|Impaired coronary flow reserve in metastatic cancer patients treated with sunitinib|
F Sen, I Yildiz, M Basaran, M Ekenel, F Oz, L Kilic, B Toz, A Gurdal, ...
J BUON 18 (3), 775-81, 2013
|Prognostic factors associated with the response to sunitinib in patients with metastatic renal cell carcinoma|
I Yildiz, F Sen, L Kilic, M Ekenel, C Ordu, I Kilicaslan, E Darendeliler, ...
Current Oncology 20 (6), 546-553, 2013
|Evaluation of serum interleukin-17 (IL-17) levels as a diagnostic marker in pancreatic adenocarcinoma|
S Karabulut, ÇU Afsar, M Karabulut, H Alış, L Kılıc, M Çikot, CT Yasasever, ...
Journal of gastrointestinal cancer 47 (1), 47-54, 2016
|Modified DCF (mDCF) regimen seems to be as effective as original DCF in advanced gastric cancer (AGC)|
S Keskin, I Yıldız, F Sen, F Aydogan, L Kilic, M Ekenel, S Saglam, B Sakar, ...
Clinical and Translational Oncology 15 (5), 403-408, 2013
|Comparison of two different adjuvant treatment modalities for pN3 gastric cancer patients after D2 lymph node dissection: can we avoid radiotherapy in a subgroup of patients?|
L Kilic, C Ordu, M Ekenel, I Yildiz, S Keskin, F Sen, Z Gural, O Asoglu, ...
Medical Oncology 30 (3), 660, 2013